Latest Investigation News

Nimy Resources has identified a 16km gold anomaly corridor at its Mons Project in Western Australia, including the new Corporate James prospect, and is preparing a drill program to test these promising targets.

AuKing Mining has kicked off a significant maiden drilling program at its Tundulu Rare Earths Project in Malawi, aiming to expand and validate rare earth mineralisation across multiple targets identified by recent surveys.

Magnum Mining has significantly increased its exploration footprint around the Piracanjuba rare earth clay discovery in Brazil, securing 14 new permits and advancing a major drilling campaign targeting a large-scale deposit.

Optiscan Imaging has reached the halfway recruitment milestone in its first in-human breast cancer study, advancing its regulatory and commercial ambitions with promising clinical data and expanded trial sites.

McLaren Minerals has reported robust initial assay results from its 13,000m drilling campaign at the McLaren Titanium Project, confirming extensive heavy mineralisation and continuity of mineralised strands that underpin resource upgrades.

Lithium Universe (ASX: LU7) has launched a detailed development program to commercialise a novel hydrometallurgical process for extracting gold and copper from electronic waste, aiming to disrupt traditional smelting with a more sustainable, low-energy method.

Strata Minerals has delivered a standout 94% hit rate in its Phase 2 drilling at the Zelica Gold Project, confirming extensive high-grade gold mineralisation and securing a development partnership to fast-track production.

Litchfield Minerals' latest drilling at Oonagalabi reveals broad copper-zinc mineralisation and an unusual nickel-molybdenum-bearing quartz vein, prompting refined geological models and planned advanced geophysical surveys.

The ACCC has approved Ampol’s acquisition of EG Australia, mandating the sale of 41 overlapping fuel retail sites to Metro Petroleum to maintain competition across 39 local markets.

Magnum Mining has completed OTCIQ submissions to secure a U.S. OTCID listing, enhancing access for American investors as it accelerates exploration across its Brazilian and U.S. rare earth, gold, and copper projects.

Cynata Therapeutics secures a crucial regulatory green light from the EMA’s Paediatric Committee for its CYP-001 treatment in children with acute graft versus host disease, paving the way for sequential adult and paediatric trials in Europe.

Tivan Limited has locked in a minimum $15 million funding package through a $10 million option underwriting agreement and a $5 million share placement with strategic investor ETFS Capital, supporting accelerated development across its Australian and Timor-Leste projects.